ReviewMedicine2026
Myxoid liposarcoma of right popliteal fossa: Case report and review.
Review in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleMyxoid liposarcoma (MLS) accounts for 30% of liposarcomas and typically arises in the thigh, but rarely arises in the popliteal fossa. Managing giant, neurovascular-abutting MLS in young adults is poorly characterized. PATIENT CONCERNS: A 35-year-old man presented with a right popliteal mass growing over > 6 years, accompanied by progressive swelling and incomplete flexion of the right knee. He denied smoking, denied alcohol use, and had no family history of malignancy. DIAGNOSES: magnetic resonance imaging showed a 179 × 154 × 99 mm multilocular cystic-solid lesion abutting/partly encasing the popliteal vessels and contacting the sciatic/common peroneal nerves. Preoperative cytology suggested benignity; definitive resection revealed MLS grade II with 20% round cell component (R1 margin adjacent to the vessel plane).
interventionsEn bloc resection with function-preserving R1 margins was performed given neurovascular involvement; popliteal artery/vein and nerves were preserved. Postoperative external-beam radiotherapy was delivered to 60 Gy in 30 fractions (2 Gy/fraction). OUTCOMES: At the 18-month follow-up, progressive recovery of knee joint range of motion was observed, and no local recurrence or metastasis at 18 months. Magnetic resonance imaging at 6 and 18 months showed no local-recurrence or metastasis. LESSONS: This case demonstrates that in young patients with popliteal MLS closely related to neurovascular structures, function-preserving R1 resection plus postoperative 60 Gy can achieve local-control while maintaining limb function, provided meticulous technique and guideline-concordant surveillance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.